147-94-4

Applied Filters:

Keyword:'147-94-4'

Showing 1-8 of 8 results for "147-94-4" within Papers

Identification of human CPI-17, an inhibitory phosphoprotein for myosin phosphatase.

K Yamawaki et al.

Biochemical and biophysical research communications, 285(4), 1040-1045 (2001-07-27)

CPI-17 is a phosphorylation-dependent inhibitor of myosin phosphatase. cDNA clones encoding CPI-17 were isolated from a human aorta library. Overlapping clones indicated two isoforms: CPI-17alpha was 147 residues and mass of 16.7 kDa; CPI-17beta (120 residues, mass 13.5 kDa) resulted

The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target.

Asem Shalaby et al.

The Journal of pathology, 223(3), 336-346 (2010-12-21)

Chordoma, the molecular hallmark of which is T (brachyury), is a rare malignant bone tumour with a high risk of local recurrence and a tumour from which metastatic disease is a common late event. Currently, there is no effective drug

Tamoxifen Application Is Associated with Transiently Increased Loss of Hippocampal Neurons following Virus Infection.

Kirsten Hülskötter et al.

International journal of molecular sciences, 22(16) (2021-08-28)

Tamoxifen is frequently used in murine knockout systems with CreER/LoxP. Besides possible neuroprotective effects, tamoxifen is described as having a negative impact on adult neurogenesis. The present study investigated the effect of a high-dose tamoxifen application on Theiler's murine encephalomyelitis

Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial.

Nick Bishop et al.

Lancet (London, England), 382(9902), 1424-1432 (2013-08-10)

Children with osteogenesis imperfecta are often treated with intravenous bisphosphonates. We aimed to assess the safety and efficacy of risedronate, an orally administered third-generation bisphosphonate, in children with the disease. In this multicentre, randomised, parallel, double-blind, placebo-controlled trial, children aged

Biodesulfurization of refractory sulfur compounds in petro-diesel by a novel hydrocarbon tolerable strain Paenibacillus glucanolyticus HN4.

Hussein N Nassar et al.

Environmental science and pollution research international, 28(7), 8102-8116 (2020-10-14)

One of the main precursors of air pollution and acid rains is the presence of the recalcitrant thiophenic compounds, for example dibenzothiophene (DBT) and its derivatives in transportation fuels. In an attempt to achieve the worldwide regulations of ultra-low sulfur

Contributions of the maternal uterine environment and piglet genotype on weaning survivability potential: II. Piglet growth, lactation performance, milk composition, and piglet blood profiles during lactation following reciprocal embryo transfers between Meishan and White crossbred gilts.

J R Miles et al.

Journal of animal science, 93(4), 1555-1564 (2015-05-29)

Crossbreeding studies between Meishan (MS) and Large White (LW) pigs have illustrated that increased piglet growth before weaning is attributed to the maternal genotype of LW dams. The objective of this study was to determine the contributions of the maternal

Pregnenolone 16 alpha-carbonitrile-inducible P-450 gene family: gene conversion and differential regulation.

F J Gonzalez et al.

Molecular and cellular biology, 6(8), 2969-2976 (1986-08-01)

A cytochrome P-450 cDNA clone, designated pP450PCN2, homologous to the previously characterized pregnenolone 16 alpha-carbonitrile (PCN)-induced P-450 cDNA (pP450PCN1; F. J. Gonzalez, D. W. Nebert, J. P. Hardwick, and C. B. Kasper, J. Biol. Chem. 260:7435-7441), was isolated from a

Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.

Kasper S Madsen et al.

The Cochrane database of systematic reviews, 12, CD008558-CD008558 (2019-12-04)

The projected rise in the incidence of type 2 diabetes mellitus (T2DM) could develop into a substantial health problem worldwide. Whether metformin can prevent or delay T2DM and its complications in people with increased risk of developing T2DM is unknown.

Page 1 of 1